Antipsychotics - depot injections
Drug Safety Update
June 2009: Antipsychotics and risk of thromboembolic events
November 2013: Risperidone and paliperidone risk of intraoperative floppy iris syndrome in patients undergoing cataract surgery
August 2020: Clozapine and other antipsychotics: monitoring blood concentrations for toxicity
Long acting depot injections are useful for maintenance treatment especially where compliance with oral treatment is unreliable. These would not be initiated within Maidstone and Tunbridge Wells NHS Trust but where patients already stabilised on a depot medication require a dose while being treated as an inpatient this will be supplied on an individual basis.
The range of depot injections used within the local health economy are those included within the Kent and Medway NHS Social Care Partnership Trust (KMPT) formulary .
Depot (long-acting) antipsychotic injections
Guidelines for acute hospital staff managing patients prescribed antipsychotic depot medication on admission can be found on the KMPT formulary here. This has been approved for use in K&M acute Trusts.
- On Formulary Preferred
- On Formulary Second Line
- On Formulary Third Line
- Specialist Initiation
- Secondary Care Only
- Not Approved for Formulary